Five steps, no guesswork — you always know exactly what comes next. Tap a step to see what it involves.
12345
You pay securely. Payment is confirmed instantly, and your receipt with the written fee breakup lands in your inbox.
Is an ESOP the right instrument for your company?
An ESOP fits well if:
You are a private limited company or startup that needs to attract senior talent you cannot yet pay full market salaries to. Equity bridges the gap between what you can pay today and what the hire is worth.
You want long-horizon retention. A four-year vesting schedule with a one-year cliff keeps people through the years that matter most — and the leaver provisions protect the company if they go.
You are building toward a liquidity event — a fundraise, acquisition or IPO — where shares will eventually have real, realisable value. Options without a credible path to liquidity are just paper.
Your investors expect it. Venture investors almost always require an option pool (typically 10–15% of fully diluted capital) to be created or expanded at each round. Having a clean, compliant scheme in place makes diligence faster.
Consider alternatives if:
You want to reward past contribution rather than future service — sweat equity (Section 54) or a one-time bonus may fit better than options that vest over years.
Your cap table is already crowded and investors resist further dilution — phantom stock or SARs deliver the economics of ownership without issuing a single share.
The company cannot credibly promise liquidity in any foreseeable horizon — employees eventually learn that options they can never sell are not compensation, and the plan breeds resentment instead of loyalty.
You need something for a very small team where the compliance cost of a formal ESOP outweighs the benefit — a well-drafted phantom stock agreement can achieve the same retention effect with a fraction of the paperwork.
What must be decided before the scheme is drafted
The option pool size. Expressed as a percentage of fully diluted share capital — 10% is the startup default, 12–15% after a Series A. Every point is future dilution, so this is negotiated with existing shareholders and often with incoming investors, who may insist the pool be created pre-money (founders absorb the dilution).
Who is eligible. Permanent employees, whole-time directors and officers of the company (and of its holding/subsidiary companies) qualify. Decide whether consultants and advisors are in or out — and document it.
Exercise price. Usually the fair market value on the grant date, or a discount for early employees — backed by a registered valuer's report. A fixed round number with no valuation behind it creates perquisite-tax trouble at exercise, because tax is computed on FMV-minus-exercise-price regardless of what the scheme says.
Vesting schedule. The standard is four years with a one-year cliff — 25% at the end of year one, the balance monthly or quarterly over three years. Alternatives include back-loaded or performance-linked vesting for senior roles. The cliff is the single most important retention feature.
Exercise window. How long after vesting the employee can buy the shares — commonly 30 days to a few years. Short windows force employees to find cash quickly; long windows are friendlier but keep ex-employees on the cap table longer.
Leaver provisions. Good leaver (resignation with notice, retirement, death, disability) vs bad leaver (termination for cause). Typically unvested options lapse for all leavers; vested options get an exercise window for good leavers and lapse for bad leavers. Vague leaver language is the number one source of ESOP disputes — define every term.
Liquidity and buyback. Will the company offer periodic buybacks before an IPO? Under Section 68, buyback up to 10% of paid-up capital plus free reserves needs only board approval; up to 25% needs a special resolution, subject to a 2:1 debt-equity ratio. A buyback policy in the scheme document turns paper wealth into something employees can plan around.
Advantages of a properly structured ESOP
It lets you hire people you cannot afford in cash
A Series A startup cannot match a listed company's salary for a VP of engineering. But a competitive salary plus options on a credible growth path is a compelling offer. The ESOP converts future company value into present hiring power.
It aligns employees with owners
An option holder thinks like a shareholder. Wasteful spending, sloppy hiring, missed targets — these stop being "the founder's problem" when the employee's own wealth is tied to the company's valuation. That alignment is difficult to buy any other way.
No cash outflow for the company
Granting options costs nothing in cash — the company receives cash when employees exercise. For a cash-constrained startup, this is the decisive advantage over cash-settled alternatives like phantom stock.
It is the industry standard investors expect
Venture term sheets routinely require an option pool of 10–15%. A company arriving at a fundraise with a compliant scheme, a maintained SH-6 register and clean board minutes signals maturity. Informal "equity promises" signal the opposite — and cost weeks in diligence.
Vesting creates genuine retention
A four-year vest with a one-year cliff means an employee who leaves at month eleven walks away with nothing. That is not cruelty; it is the mechanism working as designed. Voluntary attrition among option-holders consistently runs lower than among cash-only employees, because leaving means abandoning unvested value.
Tax-efficient compared to pure salary
Salary is taxed in full at slab rates in the year earned. ESOP gains split across two events — perquisite at exercise, capital gains at sale — and the capital-gains leg can qualify for the lower long-term rate if shares are held beyond the threshold (24 months for unlisted shares). The startup deferral stretches the first leg further.
It builds a culture of ownership
Companies that do ESOPs well talk about them openly — pool size, valuation trajectory, what the options could be worth. That transparency builds trust in a way that secretive, ad-hoc grants never do. Employees who understand their equity become the company's best recruiters.
ESOP vs SAR vs phantom stock — the comparison founders actually need
Founders often arrive asking for "an ESOP" when what they need is a decision between three different instruments. Here is the honest breakdown.
ESOP (Employee Stock Option Plan). The employee gets the right to buy real shares at a fixed exercise price after vesting. On exercise they become shareholders — with voting rights, a place on the cap table, and a Form SH-6 entry. Tax hits twice: perquisite at exercise, capital gains at sale. Compliance is the heaviest of the three: registered valuer's report, board approval, shareholder special resolution, MGT-14 within 30 days, SH-6 register maintenance, Ind AS 102 expense accounting. Best when you want genuine ownership, are heading toward liquidity, and can carry the compliance load.
SAR (Stock Appreciation Rights). The employee gets the share-value increase over the grant price, settled in cash or shares, with no exercise price. If cash-settled: no dilution, no cap-table entry — the company simply pays the appreciation. Tax is a single event (salary income with TDS). Compliance is contractual rather than statutory for private companies — meaningfully lighter to administer. Best for rewarding value creation without issuing shares.
Phantom stock. A contractual promise to pay cash linked to share value at a future date — no shares, no dilution, no voting rights, no exercise price. The employee is taxed once, as salary, on receipt. The central risk is the company's cash outflow at redemption: a cash-tight startup can find itself unable to pay vested phantom payouts. The legal framework is thin — the Companies Act is largely silent for unlisted companies — so the plan document needs unusual care. Best for founder-led companies with comfortable cash flow that want to reward senior talent without touching the cap table.
The decision in one line: choose ESOPs when ownership and a liquidity path matter; choose SARs or phantom stock when you want the retention economics without dilution or when the compliance cost of a formal ESOP is disproportionate.
Two adjacent instruments worth knowing: RSUs (Restricted Stock Units) — a promise of actual shares on vesting with no exercise price (taxed as perquisite at vesting, then capital gains at sale); and sweat equity (Section 54) — shares issued for non-cash consideration like IP or know-how, capped at 15% of paid-up capital per year (or ₹5 crore, whichever is higher), with a three-year lock-in. Sweat equity rewards past contribution; ESOPs reward future service.
Tax treatment — the two events every employee must understand
Event 1 — Exercise: perquisite tax. On exercise, the FMV-minus-exercise-price spread is treated as a perquisite under Section 17(2)(vi), added to salary income at the slab rate, with the employer deducting TDS. For listed companies the FMV is the average of the opening and closing price on the exercise date; for unlisted companies a Category I merchant banker must certify it within 180 days of exercise. This is the "dry tax" problem — tax on paper wealth, with the exercise price already paid in cash, and nothing sold yet.
Event 2 — Sale: capital gains. When the employee later sells the shares, the difference between the sale price and the FMV taken at exercise (which becomes the cost of acquisition) is taxed as capital gains. The holding period runs from the exercise date. For unlisted shares, 24 months makes it long-term; for listed shares, 12 months. Short-term gains are taxed at slab rates; long-term gains get the concessional rate.
The startup deferral. Employees of eligible DPIIT-recognised startups get relief: the employer's TDS on the exercise perquisite is deferred until the earliest of five years from the end of the exercise year, the share sale, or the employee's exit. For allotments on or after 1 April 2026, the Income-tax Act, 2025 extends this to 60 months, with the rate locked at the exercise-year rates. Eligibility is narrow — DPIIT recognition alone is not enough — and the deferred TDS must still be tracked in Form 12BA and Form 16.
For the company. ESOP expenses are deductible as business expenditure in the year the employee exercises (the discount/premium accounting under Ind AS 102 flows through the P&L over the vesting period, with the tax deduction crystallising at exercise).
Documents required
Corporate records: Board resolution approving the scheme; shareholder special resolution under Section 62(1)(b); explanatory statement under Section 102; amended Articles of Association (if the existing Articles do not authorise ESOP issuance); Form MGT-14 filing with ROC within 30 days.
Scheme documents: The ESOP scheme document itself (eligibility, pool size, vesting, exercise price mechanism, leaver provisions, acceleration clauses, administration); individual grant letters for each employee; the SH-6 Register of Employee Stock Options.
Valuation: Registered valuer's report supporting the exercise price (and, at each exercise window, the FMV for TDS computation — for unlisted companies, a Category I merchant banker's certificate dated within 180 days of exercise).
Employee-side: Exercise application from the employee; payment of the exercise price; share certificates / demat credit on allotment.
For listed companies (additional): Compliance with SEBI (SBEB and Sweat Equity) Regulations, 2021 — scheme approval, disclosures, and administration through the regulatory framework rather than the Rule 12 route.
ESOP implementation — step by step
1. Design the scheme document
Pool size, eligibility, vesting, exercise price mechanism, exercise window, leaver definitions, acceleration on acquisition/IPO, and administration. Every ambiguity here becomes a dispute later — the leaver clauses and valuation mechanism deserve the most drafting attention.
2. Obtain the valuation
A registered valuer determines the FMV anchoring the exercise price — typically a DCF or market-multiple exercise for startups. The report must be defensible; the tax department tests the exercise-date FMV against it.
3. Board approval
The board approves the scheme in principle, fixes the EGM date, and approves the draft special resolution with its explanatory statement. If the Articles do not authorise ESOP issuance, a parallel resolution to amend the Articles is prepared.
4. Shareholder special resolution
Shareholders approve the scheme by special resolution at an EGM or by postal ballot. Any individual grant exceeding 1% of issued capital needs its own separate special resolution under Rule 12(6).
5. File MGT-14 within 30 days
The certified resolution and explanatory statement go to the ROC in Form MGT-14 within 30 days. Late filing attracts additional fees and a compliance gap that surfaces in every future diligence.
6. Issue grant letters and open SH-6
Each eligible employee receives a grant letter specifying the number of options, vesting schedule and exercise price. The company opens the Register of Employee Stock Options in Form SH-6 and records every grant.
7. Administer vesting, exercise and allotment
As options vest, the SH-6 is updated. On exercise, the company collects the exercise price, allots shares, computes the perquisite, deducts TDS (or tracks the deferred TDS for eligible startups), and issues share certificates. On sale or buyback, the capital-gains leg is the employee's to report.
How long does it take?
A clean implementation — scheme drafting, valuation, board and shareholder approvals, MGT-14 filing — typically takes 3 to 6 weeks from engagement, assuming shareholders can be convened promptly. The valuation (1–2 weeks) and the EGM notice period (21 clear days, shorter with 95% consent) are the two timeline drivers. Ongoing administration is continuous: SH-6 updates at every grant, vesting and exercise event, and fresh FMV certifications at each exercise window.
How ComplyKart helps in this entire process
Scheme design. We work with the founders to fix the commercial terms — pool size, vesting, cliff, exercise window, leaver matrix, acceleration — and translate them into a scheme document that reads clearly and holds up in disputes.
Approvals and filings. We draft the board and shareholder resolutions with Section 102 explanatory statements, handle the Articles amendment if needed, and file Form MGT-14 within the 30-day window.
Valuation coordination. We engage a registered valuer, brief them on the company's stage and comparables, and ensure the report supports both the exercise price and the tax position.
Tax structuring. We map the two-stage tax incidence for the company's specific situation, set up the TDS process (including the startup deferral tracking where eligible), and brief employees so the "dry tax" never comes as a surprise.
Ongoing administration. SH-6 maintenance, grant letters, exercise processing, perquisite computation and TDS at each window, buyback support under Section 68.
What we do not do: we do not guarantee valuations will be accepted without question by the tax department, we do not backdate grants or resolutions, and we do not advise on listed-company SEBI SBEB compliance as a substitute for a SEBI-registered advisor where one is required.
What happens after the scheme is live
In the first 30 days: MGT-14 is filed, the SH-6 register is opened, and grant letters go out. Employees should receive a plain-language explainer of what they hold — vesting dates, exercise price, tax at exercise and sale — because an option nobody understands is not compensation.
In the first year: the first cliff vests. This is when the scheme meets reality — employees see value accrue for the first time, and leavers before the cliff forfeit. The company runs its first exercise window and the first perquisite/TDS cycle.
The recurring compliance you are signing up for
At every corporate action: fresh grants, vesting events, exercises, lapses and buybacks all update the SH-6. Board minutes record each tranche.
At every exercise window: fresh FMV certification (merchant banker, within 180 days for unlisted companies), perquisite computation, TDS or deferral tracking, Form 12BA and Form 16 reporting.
Annually: Ind AS 102 requires the ESOP expense to be recognised in the financial statements over the vesting period — the statutory auditor will test this. The scheme's disclosures ride along in the board's report.
On liquidity events: buybacks need Section 68 compliance (board or shareholder approval depending on size, 2:1 debt-equity test); acquisitions trigger the acceleration clauses; an IPO moves the company into the SEBI SBEB regime.
Common mistakes and how to avoid them
A round-number exercise price with no valuation. "₹10 per share" without a valuer's report does not survive scrutiny — the perquisite is computed on FMV regardless, and the company faces a TDS shortfall plus interest.
Skipping the MGT-14. The 30-day filing deadline is the most commonly missed ESOP formality in private companies. It is also the first thing a diligence team asks for.
Vague leaver clauses. "The board may decide" is not a leaver provision. Define good leaver, bad leaver, and exactly what happens to vested and unvested options in each case — including the exercise window in days.
Promising ESOPs before the scheme exists. Verbal "you'll get 1%" promises before board and shareholder approval create expectations the formal scheme may not match. Approve first, grant second.
Ignoring FEMA on cross-border grants. Options exercised by NRI or foreign-national employees mean share allotment to a person resident outside India — FC-GPR filing within 30 days on the FIRMS portal, with consideration through proper banking channels. Miss it and the allotment itself is non-compliant.
Forgetting the employee communication. The most under-invested part of every ESOP. If employees do not understand vesting, exercise mechanics and the two tax events, the retention value of the scheme is close to zero.
ESOP vs sweat equity vs RSU — quick reference
ESOP
Sweat equity (Sec 54)
RSU
What it is
Option to buy shares later at a fixed price
Shares issued now for non-cash contribution (IP, know-how)
Promise of shares on vesting, no purchase
Rewards
Future service
Past/present contribution
Future service
Employee pays
Exercise price on exercise
Nothing
Nothing
Cap per year
No statutory cap
15% of paid-up capital or ₹5 crore, whichever is higher
No statutory cap
Lock-in
As per scheme
3 years
As per scheme
Tax
Perquisite at exercise + capital gains at sale
Perquisite on discount + capital gains at sale
Perquisite at vesting + capital gains at sale
Best for
Broad retention, pre-IPO
Founders, key contributors bringing IP
Simple grants, listed companies
Sources
This page is built on the Companies Act, 2013 (Sections 2(37), 54, 62(1)(b), 68), the Companies (Share Capital and Debentures) Rules, 2014 (Rule 12), the Income-tax Act provisions on perquisites (Section 17(2)(vi)) and capital gains, the startup TDS deferral (Section 192(1C), and Sections 289(3)/392(3) of the Income-tax Act, 2025 for allotments on/after 1 April 2026), the SEBI (Share Based Employee Benefits and Sweat Equity) Regulations, 2021, and CBDT guidance on FMV certification. Tax rates, thresholds and deferral mechanics change with Finance Acts — we verify the current position at the time of engagement.
FAQ
Frequently asked questions
21 answers from our consultants.
You pay for our expert's time — document checking, filing, follow-ups — not the government. The government fee goes to the government; our fee is for the work we do so you don't have to figure it out yourself.
No legal minimum — 10% of fully diluted capital is the startup default, 12–15% after a Series A. Investors typically require the pool created or topped up pre-money at each round, so dilution falls on existing shareholders.
Yes, if the scheme includes them — most private-company schemes extend eligibility to consultants and advisors by drafting (SEBI rules for listed companies are stricter). Document eligibility clearly; ad-hoc grants outside the scheme document are where disputes start.
Not annually as a rule, but you need a defensible FMV at two points: at grant (to set the exercise price) and at each exercise window (to compute the perquisite for TDS). For unlisted companies the exercise-date FMV must come from a Category I merchant banker with a certificate dated within 180 days of exercise. In practice, high-growth startups revalue at each fundraise or annually.
At exercise, the employee owes perquisite tax on the FMV-minus-exercise-price spread — plus has paid the exercise price in cash — without having sold any shares. In an unlisted company where shares cannot be readily sold, the employee pays real tax on paper wealth. The DPIIT startup deferral exists precisely to relieve this.
Employees of an "eligible startup" — which requires DPIIT recognition plus meeting the Section 80-IAC eligibility conditions. DPIIT recognition alone is not sufficient, a point many companies get wrong. The deferral pushes the employer's TDS obligation to the earliest of five years from the end of the exercise year (60 months for allotments on/after 1 April 2026), share sale, or employment exit.
They lapse — almost universally. Unvested options are conditional on continued service, and resignation before vesting extinguishes them. This is why the cliff matters: an employee leaving at month eleven of a one-year cliff leaves with nothing vested.
The scheme's leaver provisions govern. Typically a good leaver gets a defined exercise window — 30 to 90 days is standard — to pay the exercise price and take the shares; unexercised options lapse after the window. Bad leavers often forfeit vested options or face company repurchase at the lower of cost or FMV.
Yes, under Section 68. Up to 10% of paid-up capital plus free reserves can be bought back with board approval; up to 25% needs a special resolution. The debt-equity ratio must stay within 2:1 after the buyback, and the offer follows the prescribed procedure. Many startups run annual or event-linked buybacks to give employees liquidity.
Under Ind AS 102, the fair value of options granted is recognised as an employee expense over the vesting period, with a corresponding credit to equity. The statutory auditor tests this annually. The tax deduction, however, crystallises at exercise — creating a timing difference the company should track.
ESOPs cost no cash — the company receives the exercise price. Phantom stock costs real cash at payout. But ESOPs cost dilution and heavier compliance (valuation, resolutions, MGT-14, SH-6, Ind AS 102). For a cash-tight startup, ESOPs are usually cheaper in the currency that matters; for a profitable founder-led company protective of its cap table, phantom stock can be the better trade.
Yes, but it adds a FEMA layer. Allotment of shares to a person resident outside India on exercise requires FC-GPR filing within 30 days through the FIRMS portal, and the exercise consideration must come through proper banking channels with a FIRC. The grant itself should be structured with cross-border advice from the start.
ESOPs are options to buy shares in the future, rewarding future service, with no statutory cap. Sweat equity (Section 54) is shares issued now for non-cash consideration such as IP or know-how, capped at 15% of paid-up capital per year, with a mandatory three-year lock-in. Use sweat equity to recognise contribution already made; ESOPs to incentivise contribution yet to come.
No — one special resolution approves the scheme and the total pool. Individual grants within the pool are then made by the board or a compensation committee. The exception: a grant to any single individual exceeding 1% of issued capital needs its own separate special resolution under Rule 12(6).
A Restricted Stock Unit is a promise to deliver actual shares on vesting — no exercise price, no purchase decision. Tax hits at vesting (the full FMV is a perquisite) and again at sale (capital gains on the appreciation after vesting). RSUs are simpler for employees to understand than options but give the company less cash (no exercise price is collected).
Yes. There is no legal requirement to set the exercise price at FMV. But any discount is immediately taxable as a perquisite at exercise on the full FMV-minus-price spread — a discounted exercise price does not reduce tax, it just shifts value to the employee earlier. Most companies set the price at FMV to keep the grant-date economics clean.
The SH-6 Register of Employee Stock Options (every grant, vesting, exercise, lapse); board and shareholder resolutions with explanatory statements; the MGT-14 filing acknowledgment; valuer reports; grant letters; and exercise applications with perquisite/TDS computations. Diligence teams ask for this file in every fundraise.
The scheme's acceleration clause decides. Common formulations: single-trigger (all unvested options vest on change of control), double-trigger (vesting accelerates only if the employee is also terminated post-acquisition), or assumption/conversion of options into acquirer equity. Founders negotiating an acquisition should know which version their scheme contains before the term sheet arrives.
Under the SEBI SBEB Regulations for listed companies, promoters and the promoter group are expressly excluded. Private companies are not bound by that exclusion under the Companies Act, but granting options to promoters is unusual, invites investor pushback, and can complicate the tax position. Most private-company schemes exclude promoters by drafting.
For stock options allotted on or after 1 April 2026 to employees of eligible startups, the employer's TDS on the exercise perquisite is deferred until the earliest of 60 months from the end of the tax year of allotment, the sale of shares, or cessation of employment. The tax rate is locked at the rates in force in the exercise year. Allotments before 1 April 2026 remain under the earlier 48-month framework.
Often, yes — but it requires care. Informal promises need to be mapped to a formal scheme: board approval, shareholder special resolution, MGT-14, valuation, and grant letters with proper grant dates. Backdating grants to match old promises is not acceptable; the grant date is the date the board or committee actually approves the grant. Engage early — the longer informal promises sit, the harder they are to regularise cleanly.
What clients say about working with us
Real stories from businesses we've worked with.
Trademark Registration“
Our Trademark was applied in all the classes with a short span of time by Complykart Trademark Experts and I can say the level of expertise and commitment they carry is remarkable. It's an A+ from my side. We are now sticking to ComplyKart only.
Company Registration“
I found the professionalism of the staff at complykart.com, a pleasure to work with. As a foreigner to India, they took the time to explain the documentation and assisted in every question I raised. I was pleased that complykart.com made it easy for my Business.
Merger & Acquisition“
Trust, Commitment, Dedication and responsiveness are the best things with ComplyKart. Thanks for handling our Merger assignment with so much care. After my business disputes, complykart handles all things with own sense of understanding.